FDA inspection
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company: FDA inspection ending Oct 18, 2022
FDA inspection 1181795 · No Action Indicated (NAI) · Tarrytown, NY
Key facts
| Inspection ID | 1181795 |
|---|---|
| Firm | Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company |
| FEI number | 1719513 |
| Address | 660 White Plains Rd Ste 250 |
| City | Tarrytown |
| State | NY |
| ZIP | 10591 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Oct 18, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Foodborne Biological Hazards |
| Product type | Food/Cosmetics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data